300463.SZ SHZ
Maccura Biotechnology Co.Ltd
1W: +0.8%
1M: +3.0%
3M: +11.6%
YTD: -20.7%
1Y: -24.3%
3Y: -35.0%
5Y: -74.7%
¥9.53 ($1.42)
+0.20 (+2.14%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$8.0B
-1.8% ▼
5Y CAGR: +7.7%
Total Liabilities
$1.6B
+3.0% ▲
5Y CAGR: -6.5%
Shareholders Equity
$6.4B
-0.2% ▼
5Y CAGR: +15.3%
Cash & Investments
$732M
-36.2% ▼
5Y CAGR: +10.5%
Total Debt
$446M
+39.3% ▲
5Y CAGR: -21.6%
Net Debt
-$225M
-32.0% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $612M | $637M | $587M | $836M | $671M |
| Short-Term Investments | $0 | $0 | $664M | $311M | $60M |
| Cash & ST Investments | $612M | $637M | $1.3B | $1.1B | $732M |
| Net Receivables | $2.1B | $1.9B | $2.2B | $1.9B | $1.6B |
| Inventory | $1.1B | $1.1B | $1.0B | $907M | $902M |
| Other Current Assets | $260M | $217M | $271M | $113M | $237M |
| Total Current Assets | $4.0B | $3.9B | $4.7B | $4.2B | $3.6B |
| Property, Plant & Equip. | $1.7B | $2.0B | $2.5B | $2.9B | $3.4B |
| Goodwill & Intangibles | $267M | $302M | $520M | $566M | $543M |
| Long-Term Investments | $147M | $230M | -$470M | -$138M | $114M |
| Other Non-Current Assets | $2M | $3M | $746M | $386M | $139M |
| Total Non-Current Assets | $2.3B | $2.7B | $3.5B | $3.9B | $4.3B |
| Total Assets | $6.4B | $6.6B | $8.2B | $8.1B | $8.0B |
| — Liabilities — | |||||
| Accounts Payable | $402M | $317M | $381M | $366M | $317M |
| Short-Term Debt | $922M | $531M | $400M | $145M | $255M |
| Deferred Revenue | $393M | $311M | $74M | $0 | $0 |
| Other Current Liabilities | $385M | $154M | $228M | $610M | $295M |
| Total Current Liabilities | $1.8B | $1.3B | $1.1B | $1.1B | $1.2B |
| Long-Term Debt | $330M | $424M | $286M | $162M | $184M |
| Other Non-Current Liab. | $0 | $0 | $0 | $4M | $8M |
| Total Non-Current Liabilities | $562M | $712M | $549M | $387M | $357M |
| Total Liabilities | $2.4B | $2.0B | $1.6B | $1.5B | $1.6B |
| — Equity — | |||||
| Common Stock | $557M | $556M | $612M | $612M | $612M |
| Retained Earnings | $2.6B | $3.3B | $3.7B | $3.8B | $3.9B |
| Accumulated OCI | $266M | $287M | $330M | $0 | $323M |
| Total Stockholders Equity | $3.8B | $4.3B | $6.3B | $6.4B | $6.4B |
| Total Liabilities & Equity | $6.4B | $6.6B | $8.2B | $8.1B | $8.0B |
| — Key Metrics — | |||||
| Total Debt | $1.3B | $1.1B | $701M | $320M | $446M |
| Net Debt | $709M | $478M | $114M | -$171M | -$225M |
| Total Investments | $147M | $230M | $194M | $173M | $174M |